Literature DB >> 2567157

Transient primary hypothyroidism in the newborn: experience of the Victorian Neonatal Thyroid Screening Programme.

J C Coakley1, I Francis, H Gold, K Mathur, J F Connelly.   

Abstract

Between May 1977 and December 1986, the Victorian Thyroid Screening Programme tested approximately 570,000 newborns for congenital hypothyroidism. One hundred and sixty-six cases of primary hypothyroidism, confirmed by formal thyroid function tests, were identified, of which 24 were later found to be transient. In addition, there were two patients with permanent dyshormonogenesis who passed through a stage of being biochemically euthyroid and so could have been diagnosed mistakenly as transient hypothyroidism. Fourteen of the transient cases were due to excessive intake of iodine. In two, this was due to maternal ingestion of iodide during pregnancy and in 12 the babies received large amounts of topical iodine antiseptic. Two cases were caused by maternal anti-thyroid antibodies and in eight instances the cause was unknown. The large number of cases due to the topical application of iodine antiseptic emphasizes the need for caution when using this substance in neonates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567157     DOI: 10.1111/j.1440-1754.1989.tb01408.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  3 in total

1.  Single dose povidone-iodine on thyroid functions and urinary iodine excretion.

Authors:  Deniz Yilmaz; H Tahsin Teziç; Pelin Zorlu; Serap Firat; Eriş Bilaloğlu; Alev Oğuz Kutlu
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

2.  Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data.

Authors:  Alex R Kemper; Lijing Ouyang; Scott D Grosse
Journal:  BMC Pediatr       Date:  2010-02-15       Impact factor: 2.125

3.  Prevalence of Permanent Congenital Hypothyroidism in Children in Yazd, Central Iran.

Authors:  Mahtab Ordooei; Azar RABIEi; Reza Soleimanizad; Fatemeh Mirjalili
Journal:  Iran J Public Health       Date:  2013-09       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.